Vical Incorporated today reported financial results for the three months and six months ended June 30, 2010. Revenues decreased to $2.1 million for the second quarter of 2010 from $4.0 million for the second quarter of 2009, primarily as a result of a $1.5 million milestone payment in 2009 from Merck & Co., Inc., based on Merck’s ongoing Phase 1 clinical-stage development of an investigational …

Read the rest here:
Vical second-quarter revenues decrease to $2.1 million

March 9 (Bloomberg) — Sanofi-Aventis SA and Merck & Co. will combine their veterinary medicine units to create the world’s largest animal-health business with combined sales of more than $5 billion and 14,000 employees.

Read more:
Sanofi-Aventis, Merck to Combine Animal Health Units (Update4) (Bloomberg)

March 9 (Bloomberg) — Sanofi-Aventis SA and Merck & Co. will combine their veterinary medicine units to create the world’s largest animal-health business with combined sales of more than $5 billion and 14,000 employees.

See original here:
Sanofi-Aventis, Merck to Combine Animal Health Units (Update3) (Bloomberg)